-
Novavax plans FDA filing after NanoFlu trumps Sanofi flu vaccine
pharmatimes
March 27, 2020
Novavax has unveiled new Phase III data showing that its recombinant quadrivalent seasonal influenza vaccine candidate, NanoFlu, met all primary endpoints in adults aged 65 and older against Sanofi’s Fluzone Quadrivalent.
-
Medicago announces production of a viable vaccine candidate for COVID-19
expresspharma
March 27, 2020
The biopharma successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.
-
COVID-19: UK clinical tests to start next month as global authorities see spike in unauthorised meds
pharmatimes
March 26, 2020
As the NHS announces a new major deal to expand hospital capacity to combat the spreading virus, clinical testing for vaccine candidates in the UK is being slated to start as early as next month.
-
Sartorius Supports Coronavirus Vax Candidate
contractpharma
March 26, 2020
BIOSTAT STR single-use bioreactor system used for the upstream preparation of the recombinant vaccine.
-
Akers Biosciences Licenses Premas Coronavirus Vax Candidate
contractpharma
March 26, 2020
Aims to accelerate development timeline leveraging the D-Crypt platform.
-
Hoth Therapeutics forms JV to develop Covid-19 vaccine
pharmaceutical-technology
March 25, 2020
Hoth Therapeutics has collaborated with Voltron Therapeutics to establish a joint venture (JV), HaloVax, for preclinical studies of vaccine candidates against Covid-19.
-
Argonaut’s Advanced Facility Readies to Combat COVID-19
contractpharma
March 25, 2020
Argonaut Manufacturing Services has immediate availability for aseptic drug product manufacturing fill/finish service.
-
Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals
expresspharma
March 25, 2020
DNA vaccines are produced using an inactivated virus and can manufactured faster than protein based vaccines, according to the company statement.
-
ICON Launches Coronavirus Observatory
contractpharma
March 24, 2020
Provides real-time updates on COVID-19 vaccine trials and insights into key issues.
-
University of Queensland (UQ) receives more funding for Covid-19 vaccine
pharmaceutical-technology
March 24, 2020
The regional government of Queensland and the federal Australian Government have pledged a total of $13m to University of Queensland (UQ) to support the development of its Covid-19 vaccine candidate.